Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.

Thakkar V, Stevens W, Prior D, Rabusa C, Sahhar J, Walker JG, Roddy J, Lester S, Rischmueller M, Zochling J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Clin Exp Rheumatol. 2016 May 23. [Epub ahead of print]

PMID:
27214686
2.

Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.

Owen C, Ngian GS, Elford K, Moore O, Stevens W, Nikpour M, Rabusa C, Proudman S, Roddy J, Zochling J, Hill C, Sturgess A, Tymms K, Youssef P, Sahhar J.

Clin Exp Rheumatol. 2016 Mar 24. [Epub ahead of print]

PMID:
27049330
3.

Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis.

Quinlivan A, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker JG, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Intern Med J. 2015 Nov;45(11):1134-40. doi: 10.1111/imj.12890.

PMID:
26337683
4.

Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.

Patterson KA, Roberts-Thomson PJ, Lester S, Tan JA, Hakendorf P, Rischmueller M, Zochling J, Sahhar J, Nash P, Roddy J, Hill C, Nikpour M, Stevens W, Proudman SM, Walker JG.

Arthritis Rheumatol. 2015 Dec;67(12):3234-44. doi: 10.1002/art.39316.

PMID:
26246178
5.

Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.

Moore OA, Proudman SM, Goh N, Corte TJ, Rouse H, Hennessy O, Morrisroe K, Thakkar V, Sahhar J, Roddy J, Youssef P, Gabbay E, Nash P, Zochling J, Stevens W, Nikpour M.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S111-6. Epub 2015 Aug 5.

PMID:
26243401
6.

Autologous hematopoietic stem cell transplant for systemic sclerosis improves anemia from gastric antral vascular ectasia.

Bhattacharyya A, Sahhar J, Milliken S, Ma D, Englert H, Tymms K, Danta M, Moore J.

J Rheumatol. 2015 Mar;42(3):554-5. doi: 10.3899/jrheum.141234. No abstract available.

PMID:
25729047
7.

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.

Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker J, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2015 Jan 18;17:7. doi: 10.1186/s13075-015-0517-5.

8.

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study.

Osthoff M, Ngian GS, Dean MM, Nikpour M, Stevens W, Proudman S, Eisen DP, Sahhar J.

Arthritis Res Ther. 2014 Nov 18;16(6):480. doi: 10.1186/s13075-014-0480-6.

9.

An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3.

Zochling J, Newell F, Charlesworth JC, Leo P, Stankovich J, Cortes A, Zhou Y, Stevens W, Sahhar J, Roddy J, Nash P, Tymms K, Rischmueller M, Lester S, Proudman S, Brown MA.

Arthritis Res Ther. 2014 Oct 21;16(5):438. doi: 10.1186/s13075-014-0438-8.

10.

Arterial stiffness is increased in systemic sclerosis: a cross-sectional comparison with matched controls.

Ngian GS, Sahhar J, Wicks IP, Van Doornum S.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-161-6. Epub 2014 Aug 15.

PMID:
25152081
11.

The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis.

Morrisroe KB, Stevens W, Nandurkar H, Prior D, Thakkar V, Roddy J, Zochling J, Sahhar J, Tymms K, Sturgess A, Major G, Kermeen F, Hill C, Walker J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-133-7. Epub 2014 Feb 24.

PMID:
24564981
12.

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.

Thakkar V, Stevens W, Prior D, Youssef P, Liew D, Gabbay E, Roddy J, Walker JG, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2013;15(6):R193.

13.

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.

Moore OA, Goh N, Corte T, Rouse H, Hennessy O, Thakkar V, Byron J, Sahhar J, Roddy J, Gabbay E, Youssef P, Nash P, Zochling J, Proudman SM, Stevens W, Nikpour M.

Rheumatology (Oxford). 2013 Jan;52(1):155-60. doi: 10.1093/rheumatology/kes289. Epub 2012 Oct 13.

14.

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.

Ngian GS, Stevens W, Prior D, Gabbay E, Roddy J, Tran A, Minson R, Hill C, Chow K, Sahhar J, Proudman S, Nikpour M.

Arthritis Res Ther. 2012 Oct 5;14(5):R213. doi: 10.1186/ar4051.

15.

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.

Thakkar V, Stevens WM, Prior D, Moore OA, Byron J, Liew D, Patterson K, Hissaria P, Roddy J, Zochling J, Sahhar J, Nash P, Tymms K, Celermajer D, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Arthritis Res Ther. 2012 Jun 12;14(3):R143. doi: 10.1186/ar3876.

16.

Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis.

Ngian GS, Sahhar J, Proudman SM, Stevens W, Wicks IP, Van Doornum S.

Ann Rheum Dis. 2012 Dec;71(12):1980-3. doi: 10.1136/annrheumdis-2011-201176. Epub 2012 Apr 24.

PMID:
22532628
17.

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.

Nikpour M, Hissaria P, Byron J, Sahhar J, Micallef M, Paspaliaris W, Roddy J, Nash P, Sturgess A, Proudman S, Stevens W.

Arthritis Res Ther. 2011;13(6):R211. doi: 10.1186/ar3544. Epub 2011 Dec 22.

18.

Cardiovascular disease in systemic sclerosis--an emerging association?

Ngian GS, Sahhar J, Wicks IP, Van Doornum S.

Arthritis Res Ther. 2011 Aug 26;13(4):237. doi: 10.1186/ar3445. Review.

19.

Red flags in scleroderma.

Li Q, Sahhar J, Littlejohn G.

Aust Fam Physician. 2008 Oct;37(10):831-4. Review.

20.

Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.

Proudman SM, Stevens WM, Sahhar J, Celermajer D.

Intern Med J. 2007 Jul;37(7):485-94. Review.

PMID:
17547726
Items per page

Supplemental Content

Loading ...
Write to the Help Desk